StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
This year
2
Publishing Date
2024 - 03 - 27
1
2024 - 02 - 12
1
2023 - 12 - 08
1
2023 - 11 - 01
1
2023 - 05 - 15
1
2022 - 09 - 06
1
2022 - 05 - 24
1
2022 - 04 - 26
1
2022 - 02 - 15
1
2022 - 01 - 10
1
2021 - 11 - 10
1
2021 - 10 - 25
1
2021 - 09 - 20
1
2021 - 08 - 10
1
2021 - 07 - 12
1
Sector
Communications
8
Distribution services
1
Electronic technology
3
Finance
7
Health services
3
Health technology
500
Manufacturing
15
N/a
4
Process industries
5
Professional, scientific, and technical services
8
Retail trade
1
Technology services
4
Tags
Als
1
Antibody
1
Aviptadil
1
Bioscience
2
Biotech-beach
1
Breast
1
Cancer
1
Commercialization
1
Covid
2
Covid-19
1
Diagnostics
1
Disease
1
Drug
2
Enroll
1
Financial results
1
Global
2
Growth
1
Health
1
Hepatitis
1
Israel
1
Liver
1
Market
7
Money
1
N/a
10
Nasdaq
1
Partnership
1
People
3
Reach
1
Report
1
Research
3
Results
1
Therapeutics
2
Treatment
1
Vaccine
1
Yes
1
Zyesami
1
Entities
Aadi biosciences inc
3
Abbott laboratories
1
Abbvie inc.
5
Adc therapeutics sa
1
Alnylam pharmaceuticals, inc.
1
Amgen inc.
2
Anebulo pharmaceuticals inc
1
Arrival
1
Astellas pharma inc
3
Astrazeneca plc
1
Bristol-myers squibb company
4
Cohbar, inc.
1
Cumberland pharmaceuticals inc.
1
Danaher corporation
1
Eastman kodak company
1
Eli lilly and company
3
Exelixis, inc.
1
Galmed pharmaceuticals ltd.
1
Gilead sciences, inc.
15
Grifols sa
1
Immunogen, inc.
1
Johnson & johnson
5
Morphosys ag
1
Neuropathix, inc.
1
Novartis ag
1
Novo nordisk a/s
1
Nrx pharmaceuticals inc
3
Pfizer, inc.
1
Polypid ltd.
1
Regeneron pharmaceuticals, inc.
1
Rigel pharmaceuticals, inc.
1
Sanofi
5
Sutro biopharma, inc.
1
Takeda pharmaceutical company limited
4
Teva pharmaceutical industries ltd
1
Thermo fisher scientific inc
1
Ucb s.a.
3
Urogen pharma ltd.
1
Vertex pharmaceuticals incorporated
2
Vir biotechnology, inc.
1
Zymeworks inc.
1
Symbols
AAPL
143
ABB
285
ABLZF
283
ABT
186
ALPMF
334
ALPMY
334
ALSMY
335
AMSIY
468
AMSYF
468
AOMFF
335
ARCXF
468
ARVL
4319
ATLCY
201
ATLKY
201
CETY
279
CLPBF
134
CLPBY
134
CLZNF
207
CLZNY
216
DKILF
254
DKILY
254
DNZOF
504
DNZOY
504
FNCTF
308
HITI
245
HON
283
IDBA
127
IFNNF
514
IFNNY
511
JNJ
225
LNVGF
158
LNVGY
158
MDT
151
MNK
125
MS
132
MT
468
NINOF
130
NINOY
130
NISTF
163
NJDCY
159
NPSCY
159
NRXP
181
NVS
137
NVSEF
136
PCRFF
152
PCRFY
152
PPRUF
1131
PPRUY
1132
RBGLY
218
RBGPF
218
SEKEF
283
SEKEY
283
SNEJF
133
SNY
211
SNYNF
207
STLA
536
TCLRY
182
TRUMF
255
TRUMY
255
WRAP
155
Exchanges
Nasdaq
15
Nyse
9
Crawled Date
2024 - 03 - 27
1
2024 - 02 - 12
1
2023 - 12 - 08
1
2023 - 11 - 01
1
2023 - 05 - 15
1
2022 - 09 - 06
1
2022 - 05 - 25
1
2022 - 04 - 26
1
2022 - 02 - 15
1
2022 - 01 - 10
1
2021 - 11 - 10
1
2021 - 10 - 25
1
2021 - 09 - 20
1
2021 - 08 - 10
1
2021 - 07 - 12
1
Crawled Time
01:00
1
08:00
1
10:00
1
12:00
1
12:15
1
13:00
2
13:20
1
14:00
1
14:30
1
15:15
1
18:00
1
19:00
1
20:00
2
Source
www.biospace.com
5
www.globenewswire.com
1
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Manufacturing
symbols :
GILD
save search
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published:
2024-03-27
(Crawled : 14:30)
- prnewswire.com
DHR
|
$250.41
-1.07%
-0.72%
3.3M
|
Health Technology
|
1.87%
|
O:
0.56%
H:
0.16%
C:
-0.43%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-2.58%
|
O:
1.48%
H:
0.0%
C:
0.0%
VIR
|
$8.04
-1.11%
-1.12%
770K
|
Health Technology
|
-18.46%
|
O:
0.4%
H:
2.3%
C:
0.9%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-7.43%
|
O:
0.7%
H:
0.19%
C:
0.12%
hepatitis
diagnostics
market
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-9.97%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
-13.74%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-23.05%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
4.05%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.59%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-5.22%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
32.88%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.05%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.05%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
25.99%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-2.33%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.72%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.93%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-14.12%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.82%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.94%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.555
-0.06%
-0.06%
590K
|
Health Technology
|
21.94%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-2.23%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
640.58%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
19.0%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
|
$3.47
-6.72%
-7.2%
540K
|
Health Technology
|
44.19%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
News
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-16.41%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
10.8%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published:
2023-05-15
(Crawled : 10:00)
- prnewswire.com
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
41.41%
|
O:
1.79%
H:
0.18%
C:
-0.06%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-18.53%
|
O:
0.61%
H:
0.3%
C:
0.24%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-6.92%
|
O:
0.01%
H:
0.14%
C:
-0.78%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
70.12%
|
O:
0.22%
H:
0.14%
C:
-0.2%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
15.22%
|
O:
0.35%
H:
0.83%
C:
-0.73%
VRTX
|
$400.66
-1.05%
-1.06%
810K
|
Health Technology
|
16.55%
|
O:
0.17%
H:
1.07%
C:
0.19%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.0%
|
O:
0.38%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-14.25%
|
O:
-0.13%
H:
0.42%
C:
0.4%
research
global
growth
market
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published:
2022-09-06
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
19.08%
|
O:
-3.02%
H:
0.0%
C:
0.0%
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
89.99%
|
O:
0.73%
H:
2.28%
C:
1.72%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.73%
|
O:
-0.65%
H:
0.93%
C:
0.71%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-28.64%
|
O:
0.03%
H:
1.18%
C:
0.13%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
23.22%
|
O:
-0.03%
H:
1.08%
C:
0.84%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
18.14%
|
O:
0.49%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
5.74%
|
O:
0.44%
H:
2.03%
C:
1.76%
CPIX
|
$1.61
-1.83%
-1.86%
4.5K
|
Health Technology
|
-25.79%
|
O:
-4.52%
H:
7.12%
C:
5.69%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
12.93%
|
O:
0.24%
H:
1.04%
C:
0.82%
drug
market
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
Published:
2022-05-24
(Crawled : 01:00)
- biospace.com/
KODK
|
$4.58
-1.93%
0.0%
390K
|
Electronic Technology
|
7.6%
|
O:
-2.76%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
5.29%
|
O:
0.27%
H:
0.0%
C:
0.0%
CWBR
|
$0.9004
-11.88%
21
|
Health Technology
|
400.0%
|
O:
0.17%
H:
5.38%
C:
-0.17%
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published:
2022-04-26
(Crawled : 13:20)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-14.06%
|
O:
-1.81%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
8.48%
|
O:
3.09%
H:
0.0%
C:
-2.9%
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
11.69%
|
O:
-0.33%
H:
0.0%
C:
-1.56%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
4.18%
|
O:
-1.19%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-8.41%
|
O:
-0.48%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-44.95%
|
O:
3.08%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-18.04%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
159.13%
|
O:
0.34%
H:
1.41%
C:
-1.17%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-35.58%
|
O:
-0.09%
H:
1.26%
C:
-0.51%
VRTX
|
$400.66
-1.05%
-1.06%
810K
|
Health Technology
|
49.04%
|
O:
-0.22%
H:
0.43%
C:
-1.25%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.92%
|
O:
-0.11%
H:
0.0%
C:
0.0%
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
-56.98%
|
O:
-0.38%
H:
4.92%
C:
-4.55%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
31.43%
|
O:
-0.72%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
6.99%
|
O:
-0.13%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.41%
|
O:
-0.03%
H:
0.53%
C:
-1.33%
research
report
therapeutics
market
NRx Pharmaceuticals Announces US National Institutes of Health Study of ZYESAMI® (aviptadil) in Critical COVID-19 is Cleared to Complete Full Enrollment
Published:
2022-02-15
(Crawled : 14:00)
- prnewswire.com
NRXP
5 d
|
$3.11
1.97%
1.93%
96K
|
Manufacturing
|
1.33%
|
O:
1.66%
H:
9.15%
C:
-0.65%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
9.69%
|
O:
0.01%
H:
0.65%
C:
0.35%
covid-19
zyesami
aviptadil
health
als
covid
yes
enroll
ReCode Therapeutics Appoints Shehnaaz Suliman, M.D., MBA, M.Phil., as Chief Executive Officer
Published:
2022-01-10
(Crawled : 20:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-92.05%
|
O:
1.88%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-5.94%
|
O:
1.02%
H:
0.36%
C:
0.14%
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update
Published:
2021-11-10
(Crawled : 12:15)
- globenewswire.com
AADI
|
$1.79
-2.72%
-2.79%
110K
|
Manufacturing
|
-93.22%
|
O:
-4.13%
H:
0.0%
C:
-16.65%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
1.5%
|
O:
0.65%
H:
0.0%
C:
0.0%
financial results
results
Aadi Bioscience Appoints Loretta Itri as Chief Medical Officer
Published:
2021-10-25
(Crawled : 13:00)
- biospace.com/
AADI
|
$1.79
-2.72%
-2.79%
110K
|
Manufacturing
|
-93.18%
|
O:
0.07%
H:
3.74%
C:
0.3%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.29%
|
O:
0.32%
H:
0.36%
C:
0.22%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-0.18%
|
O:
0.13%
H:
1.09%
C:
0.64%
bioscience
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
Published:
2021-09-20
(Crawled : 13:00)
- biospace.com/
AADI
|
$1.79
-2.72%
-2.79%
110K
|
Manufacturing
|
-93.73%
|
O:
-0.07%
H:
0.07%
C:
-0.82%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
48.23%
|
O:
0.16%
H:
3.69%
C:
2.54%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-5.36%
|
O:
0.14%
H:
1.4%
C:
0.04%
bioscience
NRx Pharmaceuticals to Ring Nasdaq Closing Bell on August 10, 2021
Published:
2021-08-10
(Crawled : 12:00)
- biospace.com/
NRXP
5 d
|
$3.11
1.97%
1.93%
96K
|
Manufacturing
|
-80.7%
|
O:
2.22%
H:
22.29%
C:
10.59%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-2.09%
|
O:
-0.29%
H:
1.48%
C:
1.44%
nasdaq
NRx Pharmaceuticals Announces Partnership with the Israel Institute for Biological Research to Complete Development and Commercialization of BriLife™ COVID Vaccine
Published:
2021-07-12
(Crawled : 15:15)
- prnewswire.com
NRXP
5 d
|
$3.11
1.97%
1.93%
96K
|
Manufacturing
|
-73.5%
|
O:
-2.09%
H:
31.85%
C:
-14.37%
URGN
|
$14.24
-2.0%
-2.04%
97K
|
Health Technology
|
-2.81%
|
O:
-0.74%
H:
0.74%
C:
0.2%
PYPD
|
$4.4845
4.44%
890
|
Health Technology
|
-47.36%
|
O:
4.35%
H:
0.0%
C:
-4.5%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-0.84%
|
O:
0.93%
H:
1.22%
C:
-0.23%
GLMD
|
$0.3852
6.59%
6.18%
52K
|
Health Technology
|
-87.59%
|
O:
0.69%
H:
0.0%
C:
-2.74%
covid
israel
partnership
commercialization
vaccine
research
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.